Fibrocell Science Inc (NASDAQ:FCSC)

4.87
Delayed Data
As of Feb 27
 -0.28 / -5.44%
Today’s Change
2.28
Today|||52-Week Range
6.30
+88.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$199.2M

Company Description

Fibrocell Science, Inc. develops autologous cellular system. It a commercial-stage, autologous cellular therapeutic company focused on the development of products for aesthetic, medical and scientific applications. The company has a pipeline of therapeutic and aesthetic product development programs based on the first Food and Drug Administration approved cell-based product, LAVIV™ (azficel-T), in aesthetics, all of which are based on the autologous fibroblast cell. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. Fibrocell Science was founded on September 1, 2009 and is headquartered in Exton, PA.

Contact Information

Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 713-6000
Investor Relations:

Employees

Shareholders

Mutual fund holders9.97%
Individual stakeholders38.46%
Other institutional15.17%

Top Executives

David M. PernockChairman, President & Chief Executive Officer
Kimberly M. SmithCFO, Secretary, Treasurer & Controller
John MaslowskiVice President-Scientific Affairs
Laura CampbellVice President-Planning
Robert James SheroffVice President-Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account